Black ExperienceNational

George Washington University Surpasses Minority Recruitment Goal for COVID-19 Vaccine Trial

George Washington University said half of its coronavirus vaccine trial participants are of people of color, exceeding a previously set goal of 30 percent.

GW’s 500-person trial is part of Moderna’s vaccine hopeful phase 3 program, WTTG-TV (Channel 5) reported. The university’s portion of the trial will terminate when 500 participants or 30,000 people are enrolled nationwide.

The Washington Post first reported the recruitment success, which comes despite generations of wariness of the medical profession among Blacks, partly because of the coronavirus’s disproportionate effect on the Black community. A Post data analysis found that majority-Black counties had three times the rate of infections and almost six times the rate of deaths as White-majority counties.

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker